Atara Biotherapeutics Investors Face Deadline

Shareholders have until May 22, 2026 to file claims related to losses.

Apr. 8, 2026 at 12:27am

Got story updates? Submit your updates here. ›

A photorealistic studio still-life image of a shattered glass vial or beaker on a clean, monochromatic background, representing the potential financial losses suffered by Atara Biotherapeutics investors.The shattered remains of a medical research vial symbolize the financial losses faced by Atara Biotherapeutics investors.NYC Today

Investors in Atara Biotherapeutics, Inc. have until May 22, 2026 to seek legal recourse for losses related to their investments in the company. The deadline was announced by the Hastings Tribune, which reported that the company is facing a class action lawsuit.

Why it matters

Atara Biotherapeutics is a biopharmaceutical company focused on developing novel therapies for patients with severe and life-threatening diseases. The class action lawsuit suggests there may have been issues with the company's operations or financial reporting that impacted investor returns.

The details

The class action lawsuit against Atara Biotherapeutics was filed in the United States District Court for the Southern District of New York. The lawsuit alleges that the company made false and/or misleading statements and/or failed to disclose information pertinent to investors. Shareholders who purchased Atara stock during the class period and suffered losses are eligible to join the lawsuit before the May 22, 2026 deadline.

  • The class action lawsuit was filed on April 7, 2026.
  • The deadline for investors to join the lawsuit is May 22, 2026.

The players

Atara Biotherapeutics, Inc.

A biopharmaceutical company focused on developing novel therapies for patients with severe and life-threatening diseases.

Got photos? Submit your photos here. ›

What’s next

Investors who purchased Atara Biotherapeutics stock and suffered losses are encouraged to contact a lawyer before the May 22, 2026 deadline to discuss joining the class action lawsuit.

The takeaway

This case highlights the importance for investors to closely monitor the companies they invest in and take legal action if they believe the company has misled shareholders or engaged in other wrongdoing that impacted their returns.